DOW vs PHIO · P/E 74, rev $42.96B vs $10.4M cap
Dow Inc (DOW) versus Phio Pharmaceuticals Corp (PHIO) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Phio Pharmaceuticals Corp (PHIO) is a biotechnology company listed on US.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
PHIO does not have a complete income-statement cache yet.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. PHIO currently screens at market cap $10.4M.
Not investment advice. Open the DOW and PHIO stock pages for the full models.
Not investment advice.